期刊
JOURNAL OF PHARMACOLOGICAL SCIENCES
卷 150, 期 1, 页码 1-8出版社
JAPANESE PHARMACOLOGICAL SOC
DOI: 10.1016/j.jphs.2022.05.006
关键词
Ceramide-1-phosphate; Neutrophils; Interleukin-17; Tumor necrosis factor-alpha; Monocyte chemotactic protein-1 (MCP-1)
资金
- JSPS KAKENHI [21H02631]
This study investigated the effects of CerK/C1P pathway on the onset and progression of sepsis-related events in LPS-treated sepsis-model mice. The results showed that CerK knockout increased the lethality in mice and affected the levels of various immune/inflammation-related molecules.
Ceramide, a central molecule of sphingolipid metabolism, is phosphorylated to ceramide-1-phosphate (C1P) by ceramide kinase (CerK). The CerK/C1P pathway regulates many cellular functions, but its roles in immune/inflammation-related (IIR) diseases in vivo are not well known. Sepsis is an acute systemic inflammatory disease accompanied by damage/dysfunction in multiple organs. In the present study, we investigated the effects of CerK knockout on the onset/progression of sepsis-related events in lipopolysaccharide (LPS)-treated sepsis-model mice. In CerK-null mice, the lethality at 48 h after i.v. injection of LPS was significantly increased compared with that in wild-type (WT) mice. The increased lethality by CerK knockout was reproduced in mice treated with i.p. injections of LPS. Changes in serum levels of 23 IIR molecules, including cytokines and chemokines, were measured. In WT mice, levels of these molecules increased 4 and/or 20 h after i.v. injection of LPS. Although the basal levels of IIR molecules were not affected, LPS-induced increases in interleukin-17 (IL-17), C-C motif chemokine ligands (CCL-2 and CCL-11), and tumor necrosis factor-alpha were significantly up-regulated, whereas IL-2 levels were slightly down-regulated by CerK knockout. Putative mechanisms for the CerK/C1P pathway-mediated regulation of IIR molecules and increased lethality in LPS-treated mice are discussed. (C) 2022 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据